Incidence of glucose intolerance 8 Months [clinicaltrials_resource:6498873854761d16d71fe115d78d74a6]
To examine the incidence of glucose abnormalities (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) and health outcomes (changes in body fat, waist circumference and blood lipids)in women with a history of gestational diabetes, 12 months postpartum.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Incidence of glucose intolerance 8 Months [clinicaltrials_resource:6498873854761d16d71fe115d78d74a6]
To examine the incidence of glucose abnormalities (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) and health outcomes (changes in body fat, waist circumference and blood lipids)in women with a history of gestational diabetes, 12 months postpartum.
Bio2RDF identifier
6498873854761d16d71fe115d78d74a6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6498873854761d16d71fe115d78d74a6
measure [clinicaltrials_vocabulary:measure]
Incidence of glucose intolerance
time frame [clinicaltrials_vocabulary:time-frame]
description
To examine the incidence of gl ...... iabetes, 12 months postpartum.
identifier
clinicaltrials_resource:6498873854761d16d71fe115d78d74a6
title
Incidence of glucose intolerance 8 Months
@en
type
label
Incidence of glucose intoleran ...... 8873854761d16d71fe115d78d74a6]
@en